Abstract
Background
The timing of surgical intervention in Crohn’s disease (CD) may depend on pre-operative optimization (PO) which includes different interventions to decrease the risk for unfavourable post-operative outcome. The objective of this study was to investigate the effect of multi-model PO on the post-operative outcome in CD.
Method
This is a multicentre retrospective cohort study. The primary outcome was 30-day post-operative complications. Secondary outcomes were intra-abdominal septic complications, surgical site infection (SSI), re-operation, length of post-operative stay in a hospital and re-admission. PO included nutritional support, discontinuation of medications, pre-operative antibiotic course and thrombosis prophylaxis.
Results
Two hundred and thirty-seven CD elective bowel resections were included. Mean age was 39.9 years SD 14.25, 144 (60.8 %) were female and 129 (54.4 %) had one or more types of medical treatment pre-operatively. Seventy-seven patients (32.5 %) optimized by at least nutritional support or change in pre-operative medications. PO patients were more likely to have penetrating disease phenotype (p = 0.034), lower albumin (p = 0.015) and haemoglobin (p = 0.021) compared to the non-optimized. Multivariate analyses showed that treatment with anti-TNF alpha agents OR 2.058 CI [1.043–4.4.064] and low haemoglobin OR 0.741 CI [0.572–0.0.961] increased the risk of overall post-operative complications. Co-morbidity increased the risk of SSI OR 2.567 CI [1.182–5.576] while low haemoglobin was a risk factor for re-admission OR 0.613 CI [0.405–0.926]. Low pre-operative albumin correlated with longer stay in hospital.
Conclusions
PO did not change post-operative outcome most likely due to selection bias. Anti-TNF alpha agents, low haemoglobin, low albumin and co-morbidity were associated with unfavourable outcome.
Similar content being viewed by others
References
Alós R (2008) Timing of surgery in Crohn’s disease: a key issue in the management. World J Gastroenterol 14(36):5532
Martindale RG, Deveney CW. Preoperative risk reduction: strategies to optimize outcomes. Surg Clin North Am. Elsevier Inc; 2013;93(5):1041–1055.
Spinelli A, Allocca M, Jovani M, Danese S (2014) Review article: optimal preparation for surgery in Crohn’s disease. Aliment Pharmacol Ther 40(9):1009–1022
Zangenberg M, Horesh N, Kopylov U (2016) E-HA. Systematic review on the effect of pre-operative optmization on postoperative outcome in patients with Crohn’s disease undergoing bowel resection
Burden S, Todd C, Hill J, Lal S (2012) Pre-operative nutrition support in patients undergoing gastrointestinal surgery. ( Review ) SUMMARY OF FINDINGS FOR THE MAIN COMPARISON. ;(11)
Stohs SJ, Dudrick SJ. Nutritional supplements in the surgical patient. Surg Clin North Am Elsevier Ltd; 2011;91(4):933–944, x.
Gustafsson UO, Ljungqvist O (2011) Perioperative nutritional management in digestive tract surgery. Curr Opin Clin Nutr Metab Care 14(5):504–509
Wagner IJ, Rombeau JL. Nutritional support of surgical patients with inflammatory bowel disease. Surg Clin North Am Elsevier Inc; 2011;91(4):787–803, viii.
Jacobson S (2012) Early postoperative complications in patients with Crohn’s disease given and not given preoperative total parenteral nutrition. (November 2011):170–7
Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P (2007) Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn’s disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 50(3):331–336
Subramanian V, Saxena S, Kang J-Y, Pollok RCG (2008) Preoperative steroid use and risk of postoperative complications in patients with inflammatory bowel disease undergoing abdominal surgery. Am J Gastroenterol 103(9):2373–2381
Yamamoto T, Allan RN, Keighley, MRB (1999) Risk factors for intra-abdominal sepsis after surgery in Crohn’s disease.;8507:1141–5
El-Hussuna A, Andersen J, Bisgaard T, Jess P, Henriksen M, Oehlenschlager J et al (2012) Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn’s disease. Scand J Gastroenterol 47(6):662–668
Post S, Betzler M, Ditfurth BVON, Schurmann G (1989) Risks of intestinal anastomoses in Crohn’s disease.;37–42
Canedo J, Lee S-H, Pinto R, Murad-Regadas S, Rosen L, Wexner SD (2011) Surgical resection in Crohn’s disease: is immunosuppressive medication associated with higher postoperative infection rates? Color Dis 13(11):1294–1298
Myrelid P, Olaison G, Sjödahl R, Nyström P-O, Almer S, Andersson P (2009) Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn’s disease. Dis Colon Rectum 52(8):1387–1394
El-hussuna A, Krag A, Olaisson G, Bendtsen F, Gluud LL (2013) The effect of anti-tumor necrosis factor alpha agents on postoperative anastomotic complications in Crohn’s disease: a systematic review and meta-analysis. Dis Colon Rectum
Narula N, Charleton D, Marshall JK (2013) Meta-analysis: peri-operative anti-TNFα treatment and post-operative complications in patients with inflammatory bowel disease. Aliment Pharmacol Ther 37(11):1057–1064
Ananthakrishnan AN, McGinley EL (2013) Treatment of intra-abdominal abscesses in Crohn’s disease: a nationwide analysis of patterns and outcomes of care. Dig Dis Sci 58(7):2013–2018
Bafford AC, Coakley B, Powers S, Greenwald D, Ha CY, Weintraub J et al (2012) The clinical impact of preoperative percutaneous drainage of abdominopelvic abscesses in patients with Crohn’s disease. Int J Color Dis 27(7):953–958
Müller-wille R, Iesalnieks I, Dornia C, Ott C, Jung EM, Friedrich C, et al. (2011) Influence of percutaneous abscess drainage on severe postoperative septic complications in patients with Crohn’s disease. 769–74
Xie Y, Zhu W, Li N, Li J (2012) The outcome of initial percutaneous drainage versus surgical drainage for intra-abdominal abscesses in Crohn’s disease. Int J Color Dis 27(305):199–206
Wallaert J, Randell Martino PM (2012) Venous thromboembolism after surgery for inflammatory bowel diseases: are there modifiable risk factors? Data from NSQIP. Dis Colon Rectum 29(11):997–1003
Nguyen GC. IBD: postoperative VTE prophylaxis in IBD. Nat rev Gastroenterol Hepatol. Nature Publishing Group; 2013;10(1):5–6.
Scarpa M, Pilon F, Pengo V, Romanato G, Ruffolo C, Erroi F et al (2010) Deep venous thrombosis after surgery for inflammatory bowel disease: is standard dose low molecular weight heparin prophylaxis enough? World J Surg 34:1629–1636
Zerbib P, Koriche D, Truant S, Bouras a F, Vernier-Massouille G, Seguy D et al (2010) Pre-operative management is associated with low rate of post-operative morbidity in penetrating Crohn’s disease. Aliment Pharmacol Ther 32(3):459–465
Efron JE, Young-Fadok TM (2007) Preoperative optimization of Crohn’s disease. Clin Colon Rectal Surg 20(4):303–308
Habal FM, Huang VW (2012) Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient. Aliment Pharmacol Ther 35:501–515
Sharma A, Chinn BT (2013) Preoperative Optimization of Crohn Disease.
Gross ME, Vogler S a, MC M, Sheng X, Sklow B (2014) The importance of extended postoperative venous thromboembolism prophylaxis in IBD: a National Surgical Quality Improvement Program analysis. Dis Colon Rectum 57(4):482–489
Cleynen I, Boucher G, Jostins L, Schumm LP, Zeissig S, Ahmad T et al (2016) Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study. Lancet 387:156–167
Acknowledgment
The authors would like to thank Mrs. Rikke Fog Nielsen for her efforts to collect data from the hospital register.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Local ethical approvals and data protection agency’s permission were obtained prior to start data collection in the participating centres.
Conflict of interest
The authors declare that they have no conflict of interest.
Funding
None.
Conference presentation
The study was presented in ESCP 2015, Dublin, UK.
Additional information
Alaa El-Hussuna, Igors Iesalnieks, Nir Horesh, Sabah Hadi, Yael Dreznik and Oded Zmora contributed to the manuscript.
What does this paper add to the existing literature?
This paper identifies the variability of pre-operative optimization across different countries. It is hypothesis generating and aims to be a building block for future research in the subject.
Rights and permissions
About this article
Cite this article
El-Hussuna, A., Iesalnieks, I., Horesh, N. et al. The effect of pre-operative optimization on post-operative outcome in Crohn’s disease resections. Int J Colorectal Dis 32, 49–56 (2017). https://doi.org/10.1007/s00384-016-2655-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-016-2655-x